(6E)-6-[(6-Chloro-2-methyl-2H-indazol-5-yl)imino]-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione(CAS: 2647530-73-0)

This compound is a solid with a high molecular weight. It has a crystalline form and low solubility in water. It shows moderate reactivity towards nucleophiles. The compound is stable under normal laboratory conditions but should be stored away from moisture and direct sunlight.

The compound is synthesized through a multi-step process involving the condensation of 6-chloro-2-methyl-2H-indazol-5-one with 1-methyl-1H-1,2,4-triazol-3-ylmethylamine, followed by reaction with 2,4,5-trifluorobenzyl isocyanate. The process involves the use of catalytic amounts of base and is known for its high yield and selectivity.

The compound is primarily used in the pharmaceutical industry for its potential use as a medicinal agent. It may also find applications in the development of advanced materials, such as sensors and semiconductors.

Proper personal protective equipment (PPE) should be worn, including gloves, goggles, and a lab coat. The compound should be handled in a well-ventilated area or a fume hood. Spills should be cleaned up according to standard laboratory procedures, and the Safety Data Sheet (SDS) must be consulted for specific instructions.